scispace - formally typeset
Y

Yoshio Tsuboi

Researcher at Fukuoka University

Publications -  343
Citations -  9770

Yoshio Tsuboi is an academic researcher from Fukuoka University. The author has contributed to research in topics: Medicine & Parkinsonism. The author has an hindex of 44, co-authored 306 publications receiving 8018 citations. Previous affiliations of Yoshio Tsuboi include Brown University & Chiba University.

Papers
More filters
Journal ArticleDOI

Refractory acute disseminated encephalomyelitis with anti-galactocerebroside antibody

TL;DR: This is the first report to describe concomitant involvement of the central nerve system and peripheral nervous system in anti-galactocerebroside antibody-associated acute disseminated encephalomyelitis, and to document a dramatic response to repeated intravenous immunoglobulin therapy after unsuccessful steroid treatment in one patient.
Journal ArticleDOI

Revascularization for Acute Ischemic Stroke Is Safe for Rivaroxaban Users

TL;DR: Thrombolysis and/or endovascular thrombectomy might be safe for patients treated with the new anticoagulant rivaroxaban, and an infarct was seen in an 83-year-old woman who suffered from acute ischemic stroke under treatment with NOAC.
Journal ArticleDOI

Autosomal dominant tauopathy with parkinsonism and central hypoventilation.

TL;DR: Japanese siblings with the intronic 10 + 14 splice site mutation of the microtubule-associated protein tau (MAPT) gene are described, showing parkinsonism, depression, weight loss, and central hypoventilation with reduced serotonin concentration suggested by low 5-hydroxyindole acetic acid (5-HIAA) in CSF.
Journal ArticleDOI

Impact of motor and nonmotor symptoms in Parkinson disease for the quality of life: The Japanese Quality-of-Life Survey of Parkinson Disease (JAQPAD) study

TL;DR: The importance of recognition and management of both motor and nonmotor symptoms, which together significantly affect patient QoL, are highlighted in this JAQPAD study.
Journal ArticleDOI

Dctn1 binds to tdp-43 and regulates tdp-43 aggregation

TL;DR: In this paper, the authors used a panel of truncated mutants to identify a new player in TDP-43 cytoplasmic-nuclear transport, and showed that dysregulation of DCTN1-TDP43 interactions triggers mislocalization and aggregation of TDP43, thus providing insights into the pathological mechanisms of Perry disease.